Trials / Recruiting
RecruitingNCT06443489
A Trial of SHR-4849 in Advanced Solid Tumors
A Phase I ,Open-label, Multicenter Clinical Study to Evaluate the Safety, Tolerability , Pharmacokinetics and Efficacy of SHR-4849 in Patients With Advanced Solid Tumors
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-4849 injection in Advanced Solid Tumors. To explore the reasonable dosage of SHR-4849 for Advanced Solid Tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-4849 | SHR-4849 |
Timeline
- Start date
- 2024-06-26
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-06-05
- Last updated
- 2025-03-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06443489. Inclusion in this directory is not an endorsement.